Ruta Rao

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. doi request reprint Patients with positive axillary lymph nodes: how to use genomic assays
    Ruta Rao
    Rush University Medical Center, 1725 W Harrison Street, Chicago, IL 60612, USA
    Curr Treat Options Oncol 13:240-8. 2012
  2. ncbi request reprint The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma
    Ruta Rao
    Section of Hematology, Rush University Medical Center, Chicago, IL 60612, USA
    Clin Lymphoma 6:26-30. 2005
  3. ncbi request reprint Lymphomatoid granulomatosis treated with rituximab and chemotherapy
    Ruta Rao
    Department of Hematology Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Clin Adv Hematol Oncol 1:658-60; discussion 660. 2003
  4. doi request reprint Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group
    Ruta D Rao
    Rush University Medical Center, 1725 W Harrison St, Suite 809, Chicago, IL 60612, USA
    Med Oncol 28:S39-47. 2011
  5. doi request reprint A community effort to reduce the black/white breast cancer mortality disparity in Chicago
    David Ansell
    544 Academic Facility, Rush University Medical Center, 600 South Paulina Avenue, Chicago, IL 60612, USA
    Cancer Causes Control 20:1681-8. 2009

Detail Information

Publications5

  1. doi request reprint Patients with positive axillary lymph nodes: how to use genomic assays
    Ruta Rao
    Rush University Medical Center, 1725 W Harrison Street, Chicago, IL 60612, USA
    Curr Treat Options Oncol 13:240-8. 2012
    ..Currently, the genomic assays are limited to use in tumors that are estrogen receptor positive. It is still clearly the standard of care to administer chemotherapy to estrogen receptor negative, lymph node positive tumors...
  2. ncbi request reprint The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma
    Ruta Rao
    Section of Hematology, Rush University Medical Center, Chicago, IL 60612, USA
    Clin Lymphoma 6:26-30. 2005
    ....
  3. ncbi request reprint Lymphomatoid granulomatosis treated with rituximab and chemotherapy
    Ruta Rao
    Department of Hematology Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Clin Adv Hematol Oncol 1:658-60; discussion 660. 2003
  4. doi request reprint Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group
    Ruta D Rao
    Rush University Medical Center, 1725 W Harrison St, Suite 809, Chicago, IL 60612, USA
    Med Oncol 28:S39-47. 2011
    ..This trial provides important toxicity information about fenretinide, a retinoid that has been used in the prevention setting, because it is the only placebo-controlled, double-blind randomized study ever performed...
  5. doi request reprint A community effort to reduce the black/white breast cancer mortality disparity in Chicago
    David Ansell
    544 Academic Facility, Rush University Medical Center, 600 South Paulina Avenue, Chicago, IL 60612, USA
    Cancer Causes Control 20:1681-8. 2009
    ..The Taskforce explored three hypotheses: black women in Chicago receive fewer mammograms, black women receive mammograms of inferior quality, and black women have inadequate access to quality of treatment for breast cancer...